Hong Su

Hong Su

Auto-generated profile, based on publicly available information

Hong Su

BGI-shenzhen, Shenzhen, China

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in European Urology
Verified
Journal Article
Closed access
SRShancheng Ren
Shancheng Ren
GWGong-Hong Wei
Gong-Hong Wei
DLDongbing Liu
Dongbing Liu
LWLiguo Wang
Liguo Wang
YHYong Hou
Yong Hou
YSYinghao Sun
Yinghao Sun

14 June 2018 in Blood
Verified
Journal Article
Closed access
PDF file
WRWeicheng Ren
Weicheng Ren
XYXiaofei Ye
Xiaofei Ye
HSHong Su
Hong Su
WLWei Li
Wei Li
DLDongbing Liu
Dongbing Liu
QPQiang Pan-Hammarström
Qiang Pan-Hammarström
Hepatitis B virus (HBV) infection is endemic in some parts of Asia, Africa, and South America and remains to be a significant public health problem in these areas. It is known as a leading risk factor for the development of hepatocellular carcinoma, but epidemiological studies have also shown that the infection may increase the incidence of several types of B-cell lymphoma. Here, by characterizing altogether 275 Chinese diffuse large B-cell lymphoma (DLBCL) patients, we showed that patients with concomitant HBV infection (surface antigen positive [HBsAg+]) are characterized by a younger age, a more advanced disease stage at diagnosis, and reduced overall survival. Furthermore, by whole-genome/exome sequencing of 96 tumors and the respective peripheral blood samples and targeted sequencing of 179 tumors from these patients, we observed an enhanced rate of mutagenesis and a distinct set of mutation targets in HBsAg+ DLBCL genomes, which could be partially explained by the activities of APOBEC and activation-induced cytidine deaminase. By transcriptome analysis, we further showed that the HBV-associated gene expression signature is contributed by the enrichment of genes regulated by BCL6, FOXO1, and ZFP36L1. Finally, by analysis of immunoglobulin heavy chain gene sequences, we showed that an antigen-independent mechanism, rather than a chronic antigenic simulation model, is favored in HBV-related lymphomagenesis. Taken together, we present the first comprehensive genomic and transcriptomic study that suggests a link between HBV infection and B-cell malignancy. The genetic alterations identified in this study may also provide opportunities for development of novel therapeutic strategies. Publisher9s Note: There is a Blood Commentary on this article in this issue. Key Points DLBCL patients with concomitant HBV infection are characterized by distinct clinical features. Genomic and transcriptomic analyses identified distinct mutation targets and tumorigenic pathways in HBV-associated DLBCLs. Visual Abstract

4 May 2018 in Cell Research
Verified
Journal Article
Open access
PDF file
FWFeng Wang
Feng Wang
DLDong-Bing Liu
Dong-Bing Liu
Qi ZhaoQi Zhao
Qi Zhao
GCGang Chen
Gang Chen
XLXin-Ming Liu
Xin-Ming Liu
RXRui-Hua Xu
Rui-Hua Xu

21 December 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
LPLihua Peng
Lihua Peng
LLLeo J. Lee
Leo J. Lee
HXHeng Xiong
Heng Xiong
HSHong Su
Hong Su
JRJunhua Rao
Junhua Rao
DLDongbing Liu
Dongbing Liu
Characterization of RNA editome in primary and metastatic lung adenocarcinomas Characterization of RNA editome in primary and metastatic lung adenocarcinomas